Details of the Drug

General Information of Drug (ID: DM9JV80)

Drug Name

Gp41 HIV-1 vaccine

Synonyms

FIV inhibitors, Mymetics; MYM-V101; N-36E; S-291; Anti-retrovirals, Mymetics; Gp41 HIV-1 vaccine (virosomes); Gp41-derived peptides, Mymetics; HIV-1 therapeutics, Mymetics; Gp41 HIV-1 vaccine (virosomes), Mymetics

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus infection	1C62	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0O4UZ

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Human immunodeficiency virus Glycoprotein 41 (HIV gp41)	TTG90S6	ENV_HV1H2	Modulator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT01084343) Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects. U.S. National Institutes of Health.
2	Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine. PLoS One. 2010 Jan 25;5(1):e8617.